Login:
 
Barclay C. Combined oral contraceptive pill lowers ovarian cancer risk. Practitioner Oct 2018;262(1819):5

Combined oral contraceptive pill lowers ovarian cancer risk

22 Oct 2018Registered users

Women who use the combined oral contraceptive pill (COCP) are at reduced risk of developing ovarian cancer, a benefit that persists for several years after cessation, a nationwide cohort study from Denmark has found.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.